CSPC Pharmaceutical Group (CHJTF) Stock Statistics & Valuation Metrics

CSPC Pharmaceutical Group has a market cap or net worth of $12.36B. The enterprise value is $61.00B.

Market Cap

$12.36B

Enterprise Value

$61.00B

CSPC Pharmaceutical Group has 11,522,452,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

11,522,452,000

Owned by Insiders

―

Owned by Institutions

11.61%

CSPC Pharmaceutical Group’s return on equity (ROE) is 0.11 and return on invested capital (ROIC) is 8.43%.

Return on Equity (ROE)

0.11

Return on Assets (ROA)

0.08

Return on Invested Capital (ROIC)

8.43%

Return on Capital Employed (ROCE)

0.11

Revenue Per Employee

1.36M

Profits Per Employee

203.03K

Employee Count

18,626

Asset Turnover

0.54

Inventory Turnover

2.82

The current PE Ratio of CSPC Pharmaceutical Group is 11.03. CSPC Pharmaceutical Group’s PEG ratio is 0.11.

PE Ratio

11.03

PS Ratio

2.65

PB Ratio

2.17

Price to FCF

6.70

Price to Operating Cash Flow

5.93

PEG Ratio

0.11

In the last 12 months, CSPC Pharmaceutical Group had revenue of 25.33B and earned 3.78B in profits. Earnings per share was 0.33.

Revenue

25.33B

Gross Profit

16.62B

Operating Income

3.87B

Pretax Income

4.68B

Net Income

3.78B

EBITDA

5.24B

Earnings Per Share (EPS)

0.33

In the last 12 months, operating cash flow was 13.78B and capital expenditures -1.57B, giving a free cash flow of 12.21B billion.

Operating Cash Flow

13.78B

Free Cash Flow

12.21B

Free Cash Flow per Share

1.07

CSPC Pharmaceutical Group pays an annual dividend of $0.02, resulting in a dividend yield of 3.79%

Dividend Per Share

$0.02

Dividend Yield

3.79%

Payout Ratio

91.36%

Free Cash Flow Yield

14.92%

Earnings Yield

8.95%

Beta

0.03

52-Week Price Change

19.87%

50-Day Moving Average

1.12

200-Day Moving Average

1.05

Relative Strength Index (RSI)

54.26

Average Volume (3m)

2,779

CSPC Pharmaceutical Group upcoming earnings date is Nov 13, 2026, TBA (Not Confirmed).

Last Earnings Date

Aug 20, 2026

Next Earnings Date

Nov 13, 2026

Ex-Dividend Date

Jun 26, 2026

CSPC Pharmaceutical Group as a current ratio of 2.19, with Debt / Equity ratio of 1.93%

Current Ratio

2.19

Quick Ratio

1.88

Debt to Market Cap

0.00

Net Debt to EBITDA

-1.04

Interest Coverage Ratio

102.89

In the past 12 months, CSPC Pharmaceutical Group has paid 907.61M in taxes.

Income Tax

907.61M

Effective Tax Rate

0.19

CSPC Pharmaceutical Group EV to EBITDA ratio is 7.26, with an EV/FCF ratio of 5.94.

EV to Sales

2.35

EV to EBITDA

7.26

EV to Free Cash Flow

5.94

EV to Operating Cash Flow

5.26

CSPC Pharmaceutical Group has $18.48B in cash and marketable securities with $652.37M in debt, giving a net cash position of $17.83B billion.

Cash & Marketable Securities

$18.48B

Total Debt

$652.37M

Net Cash

$17.83B

Net Cash Per Share

$1.55

Tangible Book Value Per Share

$3.18

Gross margin is 71.86%, with operating margin of 27.95%, and net profit margin of 23.73%.

Gross Margin

71.86%

Operating Margin

27.95%

Pretax Margin

29.45%

Net Profit Margin

23.73%

EBITDA Margin

32.38%

EBIT Margin

27.95%

The average price target for CSPC Pharmaceutical Group is $1.75, which is 11.43% higher than the current price. The consensus rating is Strong Buy

Price Target

$1.75

Price Target Upside

53.47% Upside

Analyst Consensus

Strong Buy

Analyst Count

12

Revenue Growth Forecast

24.82%

EPS Growth Forecast

103.02%

Smart Score

10

AI Score

―